Sunday, August 3, 2025 8/3/2025

TRANSCRIPTION & FUNCTION OF ADIPOCYTE BETA3AR IN OBESITY

Award Number: R01DK053092
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 02/01/2002
PERIOD OF PERFORMANCE END DATE: 01/31/2007

Group Awards By:

View Award Description

TRANSCRIPTION & FUNCTION OF ADIPOCYTE BETA3AR IN OBESITY - The beta3-adrenergic receptor (beta3AR) is a G protein- coupled receptor (GPCR) expressed predominantly in adipose tissue, where it mediates the effects of noradrenaline-stimulated lipolysis in white adipose tissue (WAT) and thermogenesis in brown adipose tissue (BAT). Selective agonists for the beta3AR can prevent or reverse obesity and insulin resistance in canine and rodent models, and are under pharmaceutical development for humans. In addition to potent stimulation of lipolysis, beta3AR agonists promote the appearance of thermogenically active brown adipocytes in typical white adipose depots but the mechanism responsible for this effect is not understood. Completion of the Aims in our previous funding period established that the beta3AR in adipocytes is constitutively coupled to both Galphas and Galphai, leading to the activation of the protein kinase A (PKA) and MAP kinase (ERK1/2) pathways, respectively, and that the adipocyte-specific expression of beta3AR is controlled in large part by C/EBPalpha and we defined the C/EBP site. In probing the regulation of the PKA and MAPK pathways in adipocytes by beta3AR, we have recently discovered that betaARs activate p38 MAPK kinase in adipocytes in a PKA-dependent manner, and that one of the important physiological endpoints of this regulation is the induction of the main thermogenic protein in brown fat, UCP1. Two main hypotheses are proposed. That the signaling cascade from PKA to MKK3/6 and p38 involves Rac1/cdc42 and the mixed- lineage kinases (MLKs), and that the p38 MAPK pathway is required in tandem with PKA to appropriately activate and recruit transcription factors to the UCP1-promoter, with the ultimate end point being increased thermogenesis. There are three Aims proposed: (1) to characterize the signal transduction pathway linking the betaARs in adipocytes to the p38 MAP kinase; to test the hypothesis that Rac1/Cdc42 and the MLKs are activated by PKA and, in turn, directly activate MKK3/6, the immediate upstream kinase for p38 MAPK; (2) to test the hypothesis that beta3AR- stimulation of p38 MAP kinase activity regulates PPAR-dependent transcriptional processes in adipocytes. We will test whether phosphorylation of PPARgamma and/or PGC-1 are required steps in the transactivation of the UCP1 gene, and test the hypothesis that a dual signaling cascade requiring PKA both directly and indirectly to modulate CREB and PPARgamma triggers UCP1 transcription; (3) to test the hypothesis that the orphan receptor RORgamma is a second critical transcriptional activator for the tissue-specific expression of the beta3AR gene in adipocytes. Experiments in this aim will also test the hypothesis that alterations in the profile of C/EBP proteins contribute to the obesity/diabetes dependent down-regulation of expression of the beta3AR and beta1AR genes in adipocytes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2006 ( Subtotal = $361,129 )
2006	2006	CHEMICAL INDUSTRY INSTITUTE OF TOXICOLOGY	POST OFFICE BOX 12137	RESCH TRIANGLE PK	NC	27709		USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	9	1/11/2006	NON-COMPETING CONTINUATION	$361,129
														Subtotal = $361,129

Issue Date FY: 2005 ( Subtotal = $369,820 )
2005	2005	CHEMICAL INDUSTRY INSTITUTE OF TOXICOLOGY	POST OFFICE BOX 12137	RESCH TRIANGLE PK	NC	27709		USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	8	1/31/2005	NON-COMPETING CONTINUATION	$369,820
														Subtotal = $369,820

Issue Date FY: 2004 ( Subtotal = $365,491 )
2004	2004	CHEMICAL INDUSTRY INSTITUTE OF TOXICOLOGY	POST OFFICE BOX 12137	RESCH TRIANGLE PK	NC	27709		USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	7	9/6/2004	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$318,205
2004	2004	DUKE UNIVERSITY	POST OFFICE BOX 40005	DURHAM	NC	27706	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	6	2/4/2004	NON-COMPETING CONTINUATION	$47,286
														Subtotal = $365,491

Issue Date FY: 2003 ( Subtotal = $338,800 )
2003	2003	DUKE UNIVERSITY	POST OFFICE BOX 40005	DURHAM	NC	27706	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	5		NON-COMPETING CONTINUATION	$338,800
														Subtotal = $338,800

Issue Date FY: 2002 ( Subtotal = $338,800 )
2002	2002	DUKE UNIVERSITY	POST OFFICE BOX 40005	DURHAM	NC	27706	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	2/1/2002	COMPETING CONTINUATION	$338,800
														Subtotal = $338,800

Issue Date FY: 2000 ( Subtotal = $223,386 )
2000	2000	Duke University	OFFICE OF SPONSORED PROGRAMS	DURHAM	NC	27705	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	3	5/29/2000	SUPPLEMENT FOR EXPANSION	$44,660
2000	2000	Duke University	OFFICE OF SPONSORED PROGRAMS	DURHAM	NC	27705	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	5/22/2000	NON-COMPETING CONTINUATION	$178,726
														Subtotal = $223,386

Issue Date FY: 1999 ( Subtotal = $216,061 )
1999	1999	Duke University	OFFICE OF SPONSORED PROGRAMS	DURHAM	NC	27705	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	7/14/1999	NON-COMPETING CONTINUATION	$175,123
1999	1999	Duke University	OFFICE OF SPONSORED PROGRAMS	DURHAM	NC	27705	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	2	9/23/1999	SUPPLEMENT FOR EXPANSION	$40,938
														Subtotal = $216,061

Issue Date FY: 1998 ( Subtotal = $172,017 )
1998	1998	Duke University	OFFICE OF SPONSORED PROGRAMS	DURHAM	NC	27705	DURHAM	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	7/21/1998	NEW	$172,017
														Subtotal = $172,017

Grand Total All Awards = $2,385,504

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TRANSCRIPTION & FUNCTION OF ADIPOCYTE BETA3AR IN OBESITY

Award Number: R01DK053092

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 02/01/2002

PERIOD OF PERFORMANCE END DATE: 01/31/2007

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer